Reuters logo
5 months ago
BRIEF-Biotest: European Commission approves recombinant clotting factor VIII Vihuma
March 1, 2017 / 6:13 AM / 5 months ago

BRIEF-Biotest: European Commission approves recombinant clotting factor VIII Vihuma

1 Min Read

March 1 (Reuters) - Biotest AG:

* Recombinant clotting factor VIII with the name Vihuma approved

* Market launch in Germany end of April 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below